Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.
Year: 1998
Type: article
Source: PubMed
Authors: G L DeNardo, L A Kroger, C F Meares, C M Richman, Q Salako, S Shen, K R Lamborn, J J Peterson, L A Miers, G R Zhong, S J DeNardo
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1492159527